Work

Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma

Year: 2018

Type: article

Study design: Case Report

Source: European Urology

DOI: 10.1016/j.eururo.2018.03.032

Authors: Sumanta K. Pal, Paulo Bergerot, Nazli Dizman, Cristiane Bergerot, Jacob Adashek, Russell Madison, Jon H. Chung, Siraj M. Ali, Jeremy O. Jones, Ravi Salgia

Institutions: City Of Hope National Medical Center, City of Hope, Foundation Medicine (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2802619208

FWCI: 5.747

Cites: 16

Cited by: 86

Related to: 10